LLY
996.4
-0.46%↓
JNJ
243
-0.23%↓
ABBV
228.13
+0.39%↑
NVS
155.63
-3.52%↓
AZN
192.84
-1.3%↓
LLY
996.4
-0.46%↓
JNJ
243
-0.23%↓
ABBV
228.13
+0.39%↑
NVS
155.63
-3.52%↓
AZN
192.84
-1.3%↓
LLY
996.4
-0.46%↓
JNJ
243
-0.23%↓
ABBV
228.13
+0.39%↑
NVS
155.63
-3.52%↓
AZN
192.84
-1.3%↓
LLY
996.4
-0.46%↓
JNJ
243
-0.23%↓
ABBV
228.13
+0.39%↑
NVS
155.63
-3.52%↓
AZN
192.84
-1.3%↓
LLY
996.4
-0.46%↓
JNJ
243
-0.23%↓
ABBV
228.13
+0.39%↑
NVS
155.63
-3.52%↓
AZN
192.84
-1.3%↓
24h
Current
Min
4.66
Max
4.72
Income | -269K -8.7M |
|---|---|
EPS | -0.07 |
Employees | 15 |
EBITDA | 348K -8.7M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +841.42% upside |
Market Cap | 39M |
|---|---|
Previous open | 4.26 |
Previous close | 4.69 |
By Trading Central
Confidence
Bullish Evidence
0.7955 / 0.898 Support & Resistance
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
16 sty 2026, 23:29 UTC
Stocks to Watch: Atossa Therapeutics, Union Pacific
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 45 USD 841.42%
High 105 USD
Low 10 USD
Based on 3 Wall Street analysts offering 12 month price targets forAtossa Therapeutics Inc - Dist in the last 3 months.
By TipRanks
Strong Buy
3 ratings
3
Buy
0
Hold
0
Sell
Based on 3 analysts giving stock ratings to Atossa Therapeutics Inc - Dist in the past 3 months.
By Trading Central
Short Term
Bullish Evidence
Recent bullish events outweigh bearish events.
Intermediate Term
Strong Bullish Evidence
Recent bullish events outweigh bearish events.
Long Term
Weak Bearish Evidence
There is one bearish event.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$